The merger operation consists of the acquisition, by the company TEAK Capital, B.V. (“TEAK”) and the company TANGOR Capital, S.A. (“TANGOR”) of joint control over NIH VI VOV Holdings S.à.r.l. and respective controlling subsidiaries (“VR Group”).